Correlation of TgAb With Clinicopathological Features and Unfavorable Efficacy of 131I Ablation in PTC
The Journal of Clinical Endocrinology & Metabolism · 2025
DOI: 10.1210/clinem/dgae898 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Xiang Xu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The Affiliated Hospital of Qingdao University, Qingdao 266003, China. Hauptthemen laut MEDLINE: Iodine Radioisotopes, Thyroid Neoplasms, Autoantibodies, Thyroid Cancer, Papillary. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Natural Science Foundation of Shandong Providence, Shandong Higher Education Young Science and Technology Support Program, Taishan Scholar Program of Shandong Province.
Abstract (Originalsprache)
Context
Papillary thyroid carcinoma (PTC) is the most common malignant thyroid cancer. Several clinicopathological features may affect therapeutic efficacy.
Objective
To analyze the relationship between thyroglobulin antibodies (TgAb) with clinicopathological features and efficacy of 131I ablation in PTC patients.
Methods
A total of 548 PTC patients who underwent total thyroidectomy and subsequent 131I ablation were enrolled. The clinicopathological features between TgAb-positive and TgAb-negative groups were compared. The clinicopathological characteristics and risk factors affecting the efficacy of 131I ablation were analyzed.
Results
A total of 157 cases (28.65%) were in the preoperative TgAb-positive group and 391 cases (71.35%) were in the TgAb-negative group. The TgAb-positive group was younger and had a higher proportion of females, anti-thyroid peroxidase antibody (TPOAb) positivity, multiple foci, coexistence of PTC, Hashimoto thyroiditis, and increased TSH; they had reduced FT4 and FT3, and reduced BRAF positivity (all P < .05). Logistic regression analysis showed positive correlation between TgAb positivity and multifocality (P < .05). Compared with the noneffective group (88 cases, 16.06%), the effective group (460 cases, 84.94%) had a reduced proportion of TgAb positivity and multifocality, a shorter time interval between surgery and subsequent 131I ablation, and a lower proportion of initial 131I ablation dosage > 100 mCi (all P < .05). Logistic regression showed that TgAb positivity, longer time interval between surgery and subsequent 131I ablation, and initial 131I ablation dosage > 100 mCi were positively correlated with nonefficacy of 131I ablation (odds ratios 2.248, 1.012, and 3.128, respectively; P < .05).
Conclusion
TgAb positivity is associated with increased risk of multiple foci and unfavorable efficacy of 131I ablation in PTC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, The Affiliated Hospital of Qingdao University, Qingdao 266003, China.
- Department of Endocrinology and Metabolism, The Affiliated Hospital of Qingdao University, Qingdao 266003, China.
- Department of Endocrinology, Pingdu People's Hospital, Qingdao 266700, China.
- Department of Nuclear Medicine, The Affiliated Hospital of Qingdao University, Qingdao 266003, China.
- Department of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.
- Department of Echocardiography, The Affiliated Hospital of Qingdao University, Qingdao 266003, China.
ORCID-Profile: Bingzi Dong, Yangang Wang, Kun Gong
Förderung
- Natural Science Foundation of Shandong Providence
- Shandong Higher Education Young Science and Technology Support Program
- Taishan Scholar Program of Shandong Province
Zitieren
APA
Xu, X., Zhang, C., Wang, G., Dong, B., Guo, Y., Xing, B., Zhao, W., Wang, Y., & Gong, K. (2025). Correlation of TgAb With Clinicopathological Features and Unfavorable Efficacy of 131I Ablation in PTC. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae898
Vancouver
Xu X, Zhang C, Wang G, Dong B, Guo Y, Xing B, et al. Correlation of TgAb With Clinicopathological Features and Unfavorable Efficacy of 131I Ablation in PTC. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgae898
BibTeX
@article{Xu2025,
author = {Xu, Xiang and Zhang, Chunling and Wang, Guoqiang and Dong, Bingzi and Guo, Yanjun and Xing, Baodi and Zhao, Wenjuan and Wang, Yangang and Gong, Kun},
title = {Correlation of TgAb With Clinicopathological Features and Unfavorable Efficacy of 131I Ablation in PTC},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2025},
doi = {10.1210/clinem/dgae898}
}
EUVIMED